These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9775281)

  • 21. Evidence-based orthopaedics: a primer.
    Schünemann HJ; Bone L
    Clin Orthop Relat Res; 2003 Aug; (413):117-32. PubMed ID: 12897602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stroke--possibilities for prevention].
    Kolominsky-Rabas P
    Biomed Tech (Berl); 2005; 50(7-8):233-7. PubMed ID: 16117437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions.
    Mayne TJ; Whalen E; Vu A
    J Clin Epidemiol; 2006 Mar; 59(3):217-23. PubMed ID: 16488351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating adjusted NNT measures in logistic regression analysis.
    Bender R; Kuss O; Hildebrandt M; Gehrmann U
    Stat Med; 2007 Dec; 26(30):5586-95. PubMed ID: 17879268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Number needed to treat: a useful tool for estimating the effectiveness of a treatment].
    van Harten PN
    Tijdschr Psychiatr; 2008; 50(6):337-43. PubMed ID: 18548411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primer: Demystifying risk--understanding and communicating medical risks.
    Crowson CS; Therneau TM; Matteson EL; Gabriel SE
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):181-7; quiz 1 p following 187. PubMed ID: 17334341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk and odds--how to calculate with events].
    Malmquist J
    Lakartidningen; 2002 Feb; 99(8):751-3, 756. PubMed ID: 11894612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based medicine, part 2. An introduction to critical appraisal of articles on therapy.
    Cardarelli R; Virgilio RF; Taylor L
    J Am Osteopath Assoc; 2007 Aug; 107(8):299-303. PubMed ID: 17785686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deriving treatment recommendations from evidence within randomized trials. The role and limitation of meta-analysis.
    Freemantle N; Mason J; Eccles M
    Int J Technol Assess Health Care; 1999; 15(2):304-15. PubMed ID: 10507190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Search and appraisal of literatures and methods to use Internets in evidence based neurology].
    Uchiyama S
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1182-5. PubMed ID: 12784700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat.
    Gensini GF; Conti AA
    Ital Heart J; 2003 Feb; 4(2):80-3. PubMed ID: 12762269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing pressure ulcer incidence through Braden Scale risk assessment and support surface use.
    Comfort EH
    Adv Skin Wound Care; 2008 Jul; 21(7):330-4. PubMed ID: 18600075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of the 'reverse Cornfield inequality' to assess the sensitivity of a non-significant association to an omitted variable.
    Yu B; Gastwirth JL
    Stat Med; 2003 Nov; 22(21):3383-401. PubMed ID: 14566922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expressing medicine side effects: assessing the effectiveness of absolute risk, relative risk, and number needed to harm, and the provision of baseline risk information.
    Berry DC; Knapp P; Raynor T
    Patient Educ Couns; 2006 Oct; 63(1-2):89-96. PubMed ID: 16242904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative risks and odds ratios: what's the difference?
    Last A; Wilson S
    J Fam Pract; 2004 Feb; 53(2):108. PubMed ID: 14764292
    [No Abstract]   [Full Text] [Related]  

  • 37. [Assessment of therapeutic efficacy, an essential step in evidence-based medicine].
    Scheen AJ
    Rev Med Liege; 2000 Apr; 55(4):206-10. PubMed ID: 10909301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measures of effect in epidemiological research.
    Tripepi G; Jager KJ; Dekker FW; Zoccali C
    Nephron Clin Pract; 2010; 115(2):c91-3. PubMed ID: 20407271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating a treatment effect: Choosing between relative and absolute measures.
    Sormani MP; Bruzzi P
    Mult Scler; 2017 Feb; 23(2):197-200. PubMed ID: 27207463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Odds ratio, relative risk, absolute risk reduction, and the number needed to treat--which of these should we use?
    Schechtman E
    Value Health; 2002; 5(5):431-6. PubMed ID: 12201860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.